MTOR and neoplasm: In fact, the long-term use of the mTOR inhibitor Everolimus to inhibit tumor growth and spread has been unsuccessful due to resistance caused by genomic instability induced by long-term treatment with Everolimus, but the underlying mechanisms are currently unclear (Burrell and Swanton, 2014).